NON-CHEMOTHERAPEUTIC AGENTS THAT POTENTIATE CHEMOTHERAPY EFFICACY

[21] BECK WT, 1986, CANCER RES, V46, P778

[22] BECK WT, 1984, P AM ASSOC CANC RES, V25, P334

[23] INVITRO AND INVIVO ENHANCEMENT OF VINCRISTINE ANTITUMOR-ACTIVITY ON B-16 MELANOMA-CELLS BY CALCIUM-ANTAGONIST FLUNARIZINE [J]. ONCOLOGY, 1987, 44 (01) : 17 - 23

[24] BELT JA, 1985, P AM ASSOC CANC RES, V26, P264

[25] BENSON AB, 1985, CANCER TREAT REP, V69, P795

[26] BENSON AB, 1984, P AM ASSOC CANC RES, V25, P162

[27] BERGERAT JP, 1981, CANCER RES, V41, P25

[28] TREATMENT OF CHILDREN WITH REFRACTORY ACUTE LYMPHOCYTIC-LEUKEMIA WITH VINCRISTINE AND DILTIAZEM [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (04): : 199 - 202

[29] FACTORS INVOLVED IN DEPLETION OF GLUTATHIONE FROM A549 HUMAN-LUNG CARCINOMA-CELLS - IMPLICATIONS FOR RADIOTHERAPY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (08): : 1221 - 1227

[30] BICHAY TJ, 1986, P AM ASSOC CANC RES, V27, P392

[21] BECK WT, 1986, CANCER RES, V46, P778

[22] BECK WT, 1984, P AM ASSOC CANC RES, V25, P334

[23] INVITRO AND INVIVO ENHANCEMENT OF VINCRISTINE ANTITUMOR-ACTIVITY ON B-16 MELANOMA-CELLS BY CALCIUM-ANTAGONIST FLUNARIZINE [J]. ONCOLOGY, 1987, 44 (01) : 17 - 23

[24] BELT JA, 1985, P AM ASSOC CANC RES, V26, P264

[25] BENSON AB, 1985, CANCER TREAT REP, V69, P795

[26] BENSON AB, 1984, P AM ASSOC CANC RES, V25, P162

[27] BERGERAT JP, 1981, CANCER RES, V41, P25

[28] TREATMENT OF CHILDREN WITH REFRACTORY ACUTE LYMPHOCYTIC-LEUKEMIA WITH VINCRISTINE AND DILTIAZEM [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (04): : 199 - 202

[29] FACTORS INVOLVED IN DEPLETION OF GLUTATHIONE FROM A549 HUMAN-LUNG CARCINOMA-CELLS - IMPLICATIONS FOR RADIOTHERAPY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (08): : 1221 - 1227

[30] BICHAY TJ, 1986, P AM ASSOC CANC RES, V27, P392